secwatch.observer — SEC 8-K summary
======================================

Issuer:     CareDx, Inc. (CDNA)
CIK:        0001217234
Form:       8-K
Filed at:   2025-08-06T23:59:59+00:00
Accession:  0001217234-25-000045
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01, 5.02, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

CareDx Q2 adjusted revenue up 14% YoY to $90.5M; narrows FY guidance; appoints new CFO
--------------------------------------------------------------------------------

- Q2 adjusted revenue $90.5M (+14% YoY); GAAP revenue $86.7M (-6% YoY) due to $3.8M aged receivable write-off.
- Testing services volume ~49,500 (+13% YoY); AlloSure Kidney volume up ~20% YoY.
- GAAP net loss $8.6M ($0.16/sh) vs $4.6M loss; non-GAAP net income $5.6M ($0.10/sh) vs $13.6M.
- Adjusted EBITDA $9.1M (excl. $3.8M write-off) vs prior year loss $0.3M.
- CFO change: Nathan Smith appointed, effective Aug 7, 2025; Abhishek Jain retired; Smith receives $400K salary, RSUs, PSUs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1217234/000121723425000045/0001217234-25-000045-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1217234/000121723425000045/cdna-20250806.htm
  HTML page:      https://secwatch.observer/filing/0001217234-25-000045

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer